INTRODUCTION
Addition of interferon (IFN) to the culture medium of mammalian cells prevents virus growth (Stewart, 1981) . IFN interacts with the cell surface and induces the so-called antiviral state. The establishment of this antiviral state requires gene expression (Taylor, 1964; Lockart, 1964; Friedman & Sonnabend, 1965) . At least two proteins have been suggested as candidates which interfere with virus development. One of the~e is a protein kinase that, in the presence of dsRNA, phosphorylates a 67 000 mol. wt. cellular protein and a subunit of initiation factor elF 2 (Kimchi et al., 1979; Hovanessian et al., 1980; Gupta et al., 1982) . Another is a 2'-5' oligo(A) synthetase that uses ATP as substrate and synthesizes oligo(A) containing 2'-5' bonds. This enzyme is also activated by the presence of dsRNA (Baglioni, 1979; Revel, 1979) . The 2'-5' oligo(A) synthesized is, in turn, a potent stimulator of a constitutive cellular nuclease that degrades RNA (Rather et al., 1977; Baglioni et al., 1978) . Both mechanisms lead to the inhibition of protein synthesis. The evidence of their involvement in the antiviral state is mainly based on observations in vitro (Williams & Kerr, 1980; Lengyel, 1982) . The action of any of these mechanisms in the infected cell will block viral protein synthesis and, in some instances, it will also inhibit cellular translation. Most of the animal viruses studied do not synthesize proteins in interferon-treated cells, with perhaps the only known exception at present being retroviruses (Friedman, 1977; Sen, 1982) .
In an attempt to know how generally the mechanisms described above operate in vivo for RNA-containing animal viruses, we have done comparative studies on viral protein synthesis in interferon-treated human cells infected with vesicular stomatitis virus (VSV; rhabdoviruses), Newcastle disease virus (NDV; paramyxoviruses), influenza virus (orthomyxoviruses), Semliki Forest virus (SFV; togaviruses), encephalomyocarditis (EMC) virus and poliovirus (picornaviruses) and reovirus.
Eagle's medium (E4D) supplemented with 10~o calf serum (E4D 10 medium) and incubated at 37 °C in a 5 ~ CO2 atmosphere. Poliovirus type 1 and NDV were grown on HeLa cells in E4D medium supplemented with 2~ newborn calf serum; SFV and VSV were grown in BHK-21 ceils in the same medium. EMC virus was grown on L929 cells in a mixture of Eagle's medium, phosphate-buffered saline (PBS) solution and E4D medium (80 : 15 : 5) supplemented with 1 ~ newborn calf serum.
In all cases, the fraction obtained after removal of cell debris by low-speed centrifugation was used as source of virus. Influenza A virus was kindly donated by Dr L. del Rio, and reovirus type 3 Dearing strain was purchased from the American Type Culture Collection.
Virus infection and measurement of protein synthesis. Cells grown on 24-well plates (Falcon Plastics) were infected with EMC virus at the m.o.i, described in each experiment. After 1 h incubation at 37 °C, the medium was removed and 1 ml E4D2 was added. The time of virus addition was considered as -1 h and 0 time was taken as when the virus was removed. Incubation at 37 °C was continued until the labelling period. For this purpose, 0.5 ml methionine-free E4D1 medium and 0.11 ~tCi [3sS]methionine (1100 Ci/mmol, 5.4 mCi/ml; Amersham) were added to the cells for a 1 h pulse. The medium was then removed, the cells were washed with PBS solution and precipitated with 5~ trichloroacetic acid (TCA). After 5 min, the TCA was removed and the cell monolayer washed three times with ethanol, dried under an infrared lamp and dissolved in 250 p.10-1 M-NaOH plus 1 ~ SDS. Samples of 125 p.1 were counted in an Intertechnique scintillation spectrometer.
Analysis of the proteins synthesized in virus-infected cells. HeLa cells or LLC-MK2 cells were grown on 30 mm
Petri dishes and pulsed with 5.4 pCi [35S]methionine. At the end of the pulse period, the ceils were washed with 1 ml PBS solution and dissolved in 200 ~tl 0.02 M-NaOH plus 1 ~o SDS and 200 ~tl sample buffer (62.5 mM-Tris-HC1 pH 6-8, 2~ SDS, 0-1 M-dithiothreitol, 17~ glycerol, and 0.024~ bromophenol blue as indicator). Each sample was sonicated to reduce viscosity and heated to 90 °C for 5 min. Ten pl was applied to a 15~ polyacrylamide gel and run overnight at 30 V. Fluorography of the gel was carried out with 2,5-diphenyloxazole at 20~ (w/w) in dimethyl sulphoxide. The dried gels were exposed using XS-5 X-ray films (Kodak). Densitometric profiles of the gel were done in an Optronics P1700 microdensitometer.
Interferon. Human lymphoblastoid interferon, HulFN-a(Ly) at 1-6 × 106 IU/ml protein, was a generous gift of Measurement of86Rb + content. HeLa cells grown in E4DI0 medium were placed in 280 Ixl of a mixture of methionine-free E4D1 medium : E4D10 medium (3 : l), 0.2 ~tCi 86Rb+ (1 mCi/ml; Amersham) was added, and the cells were incubated for 17 h at 37 °C. Virus infection was then carried out while the 86Rb+ concentration was maintained constant. At the times indicated, the cells were pulse-labelled with 0.14 ~tCi [35S]methionine. After 1 h incubation, the medium was removed and the cells were washed three times with 1 ml PBS, and 0.5 ml 5 ~ TCA was added to extract the 86Rb÷ from the cells. The radioactivity of 0.4 ml of the TCA extract was determined by estimating the Cerenkov radiation in a liquid scintillation counter. The level of protein synthesis was estimated in parallel cultures as described above.
Plaque assay. The virus (0.5 ml) was added to HeLa cell (poliovirus, NDV, reovirus), L929 cell (EMC virus) or BHK cell (SFV, VSV) monolayers. The plates were tilted every 15 min to distribute the virus solution evenly. Sixty minutes after infection with poliovirus, NDV, SFV or VSV or 90 rain after infection with reovirus, the monolayers were overlaid with 6 ml of growth medium supplemented with 3~ calf serum and 0-7~ purified agar (Oxoid) (plus 25 mM-MgCI2, 2-5 mM-arginine and 100 pg/ml DEAE-dextran in the case of reovirus) and were further incubated at 37 °C. Plaques were counted 4 h after staining with 0.06~ neutral red, at 1 (poliovirus, VSV), 2 (EMC virus, SFV, NDV) or 5 (reovirus) days after infection.
Analysis of protein glycosylation. HeLa cells were grown on 30 mm Petri dishes and pulsed with 15 ~tCi/ml D-[6-3H]glucosamine hydrochloride (29 Ci/mmol, 1.0 mCi/ml; Amersham) in E4 medium without glucose but containing 10 times the normal pyruvate concentration, plus 2~ calf serum dialysed against PBS solution. The processing was as described for the [35S]methionine-labelled proteins.
RESULTS

Action of HulFN-~(Ly) on animal viruses containing a negative-stranded RNA genome
Three different virus species that belong to three different animal virus families were studied for their development in HeLa cells treated with HuIFN-cc(Ly) ( Table 1 ).
Vesicular stomatitis virus (rhabdovirus)
Previous studies on the development of VSV in interferon-treated cells have shown that viral replication is strongly inhibited (Stewart, 1981 ). This inhibition is most probably primarily located at the level of viral RNA replication and, as a consequence, no viral proteins are synthesized (Marcus et al., 1971 ; Manders et al., 1972) . In contrast, the shut-off of host protein synthesis after VSV infection is not prevented by IFN treatment (Yamakazi & Wagner, 1970) . There is also some evidence suggesting that viral protein synthesis is the primary target of the antiviral action induced by IFN and as a consequence secondary viral transcription is blocked (Repik et al., 1974; Baxt et al., 1977) . A possible basis for the discrepancies observed lies in the cell line used. In some instances, primary transcription is the main target for the antiviral action of interferon, whereas, in other instances, the target is the translation of viral mRNAs (Thacore, 1978) . Both mechanisms could even operate simultaneously (Marcus & Sekellick, 1978) . More recent findings indicate that significant levels of VSV protein synthesis take place in HeLa cells treated with human fibroblast interferon, under conditions where the synthesis of viral transcripts are not blocked (Simili et al., 1980) . Apparently, a defect in the capping of viral mRNA could be responsible for that partial block in viral translation (de Ferra & Baglioni, 1981) . More difficult to interpret are the findings of Friedman's group, showing that the antiviral effect of IFN was exerted at the level of glycosylation of the viral G glycoprotein (Maheswari et al., 1980a, b) . In contrast, the results of more recent experiments by Olden et al. (1982) do not agree with that mechanism.
To gain more insight into this problem, we first analysed the time course of protein synthesis in VSV-infected HeLa cells treated with various concentrations of HulFN-~(Ly). Fig. 1 shows that treatment of human cells with concentrations of lymphoblastoid interferon above 10 IU/ml profoundly inhibited viral protein synthesis. However, cellular translation continued unabated under the conditions used in this experiment. This result contrasts with that reported by Simili et al. (1980) 
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To analyse the discrepancies recently reported with respect to the antiviral effects of I F N and the level of glycosylation of viral protein G, we carried out the experiment shown in Fig. 2 . The glycosylation of cellular proteins in control ceils not treated with interferon but infected with VSV was not observed from the 4th hour post-infection; only the viral G protein appears glycosylated. Treatment of cells with increasing amounts of HulFN-ct(Ly) reduced the level of glycosylation of the G protein, whereas the pattern of glycosylation of cellular proteins was unchanged. Estimation of the reduction of glycosylation of protein G by densitometric analysis indicated that it parallels the inhibition of synthesis of this protein (see Fig. 1 ). Therefore, our results, instead of supporting the idea that specific inhibition of glycosylation of viral protein G occurs in IFN-treated cells, show, rather, that no viral proteins are made. To analyse the effect of the multiplicity of infection on cellular and viral protein synthesis, we infected both control and IFN-treated cells with 10 or 100 p.f.u./cell of VSV (Fig. 3) . At either m.o.i., no viral protein synthesis was detected in IFN-treated cells. However, we found that the shut-off of host protein synthesis occurred in IFN-treated cells only when the high m.o.i, was used. We have described a similar situation for IFN-treated cells infected with EMC virus (Mufioz & Carrasco, 1981) . These data are particularly interesting, since inhibition of cellular protein synthesis can take place even with no VSV proteins being made. This suggests that, at least in this situation, the shut-off of translation induced by VSV infection is not due to competition of viral m R N A s for components of the translation machinery, as has been suggested (Lodish & Porter, 1980) . A number of animal viruses modify membrane permeability during virus infection (Kohn, 1979; Carrasco & Smith, 1980) . We considered it of interest to analyse permeability to S6Rb + ions in cells infected at high m.o.i., since under these conditions shut-off of protein synthesis occurs even in cells treated with interferon. Fig. 4 (b) shows that HeLa cells not treated with IFN gradually lose 86Rb+ ions, in agreement with Garry & Waite's (1979) results indicating a redistribution of sodium and potassium ions in VSV-infected cells, as measured by flame spectrophotometry. No modification of membrane permeability in IFN-treated cells is observed, even though cellular protein synthesis is partially blocked (Fig. 4a) .
Newcastle disease virus (paramyxovirus)
Infection of HeLa cells with NDV leads to massive synthesis of viral proteins which are seen from the 5th hour post-infection. At about this time, inhibition of host protein synthesis commences and, finally, from the 16th hour post-infection hardly any viral or cellular proteins are made. If cells were treated with HulFN-~(Ly), virus production was reduced (Table 1 ) and viral proteins were not detected, but cellular translation was progressively inhibited (Fig. 5) . This situation resembles that described above for VSV. To our knowledge, no data have been reported on the action of human interferon on NDV protein synthesis, nor on the inhibition of influenza virus replication. 
Influenza virus (orthomyxovirus)
Influenza
Action of HulFN-~(Ly) on animal viruses containing a positive-stranded RNA genome
Viruses that belong to two different families have been tested for their development in HuIFN-c~(Ly)-treated HeLa cells: Semliki Forest virus, a togavirus, and two picornaviruses, EMC virus and poliovirus.
Semliki Forest virus (togavirus)
I F N has a very potent activity against SFV replication: as little as 2 IU/ml of HuIFN-~(Ly) was sufficient to prevent the appearance of the cytopathic effect completely, even when HeLa cells are infected with 100 p.f.u./cell (Fig. 7) . Higher m.o.i, led to cell death, but even this effect was prevented by treatment with a moderate concentration of HuIFN-~(Ly) (50 IU/ml). 
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Analysis of the proteins synthesized in IFN-treated cells indicated that a complete blockage of late SFV proteins takes place (Fig. 8) . In agreement with the result shown in Fig. 7 , no shut-off of host protein synthesis after SFV infection was observed in HulFN-~(Ly)-treated cells.
EMC virus and poliovirus (picornaviruses)
The inhibition of EMC virus protein synthesis in HuIFN-~(Ly)-treated HeLa cells has already been described (Mufioz & Carrasco, 1981) . For the present purposes, we want to point out only that this system is similar to that described above for VSV : shut-off of host protein synthesis in IFN-treated cells only occurs when high m.o.i, of EMC are used; at low m.o.i., the inhibition of cellular translation is prevented by treatment of cells with IFN. This behaviour is different for poliovirus: in this case, the shut-off of host protein synthesis in IFN-treated cells occurred even at low m.o.i., though viral protein synthesis was prevented (Fig. 9) .
Action of HulFN-~(Ly) on animal viruses containing a double-stranded RNA genome
Reovirus
Reovirus contains as genome double-stranded RNA segmented in ten different pieces (Joklik, 1981) . The synthesis of reovirus proteins in HeLa cells becomes apparent from the 10th hour post-infection, with a gradual decline of total protein synthesis from that time onwards (Fig. 10) . Interestingly enough, cells treated with interferon synthesize approximately equal amounts of reovirus proteins, even though the production of new infective particles is reduced (Table 1) . This virus system seems to us particularly interesting, since a virus that certainly synthesizes dsRNA during its replication cycle does not, however, inhibit the synthesis of its own proteins.
DISCUSSION
In the attempt to understand the molecular basis of the antiviral action of interferon, a great amount of work has been done on cell-free systems derived from IFN-treated cells. Addition of dsRNA to these systems in vitro has revealed the activation of a protein kinase and the synthesis of the compound 2'-5' oligo(A), a nuclease activator (Baglioni, 1979; Revel, 1979; Williams & Kerr, 1980) . In comparison, very little is known about the mechanism of inhibition of virus protein synthesis in intact IFN-treated cells. For instance, no data are available about the synthesis of viral proteins in IFN-treated cells infected by NDV or influenza viruses. We know of only one experiment on the analysis of SFV proteins in IFN-treated cells (Friedman, 1968) . (Kitamura et al., 1981) .
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As regards the synthesis of viral proteins in IFN-treated cells, the.experiments reported in this work divide RNA animal viruses in two distinct groups: those that synthesize viral proteins to control levels in IFN-treated cells (influenza virus and reovirus), and those where the translation of viral mRNAs is not detected. In the latter group, differences in behaviour exist as regards their inhibition of host protein synthesis. Some viruses, such as poliovirus, do shut off host translation in IFN-treated cells even at low m.o.i., whereas in other systems, such as with SFV, there is no blockage of translation even at multiplicities as high as 400 p.f.u./cell.
With regard to VSV, a direct parallelism exists between the inhibition of infective virus particle formation and the decrease in the synthesis of viral proteins. Our data, however, do not discriminate between a direct inhibition of viral translation in the interferon-treated cell and an indirect effect as a consequence of inhibition of primary transcription. Nevertheless, it seems clear that there is not a preferential inhibition of glycosylation of the G protein, in agreement with more recent data (Olden et al., 1982) . Even more recently a specific inhibition of the incorporation of G and M into virions has been claimed as the basis of the antiviral effects of interferon against VSV (Jay et al., 1983 ). This possibility is not supported by our data.
With respect to changes in the membrane during VSV infection, Francoeur & Stanners (1978) claimed that VSV infection does not modify membrane permeability. Further studies by Garry & Waite (1979) , however, demonstrated that this was not so. Our present results are in agreement with the idea that VSV infection modifies permeability to monovalent ions throughout infection. This result also agrees well with the findings on the entry of some inhibitors into VSV-infected ceils (Benedetto et al., 1980) . However, this modification of permeability is prevented if cells are treated with interferon. Recently, Lodish & Porter (1980) Time ( h a v e suggested t h a t the cessation of host t r a n s l a t i o n in VSV-infected cells is due to c o m p e t i t i o n of cellular m R N A by more efficient viral m R N A s , giving rise to preferential synthesis of viral proteins from the period 4 to 5 h post-infection. Obviously, this m e c h a n i s m is not operative in I F N -t r e a t e d cells, since, a l t h o u g h no viral protein synthesis takes place, i n h i b i t i o n of Cellular protein synthesis ensues.
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